Skip to content

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07398365
Enrollment
100
Registered
2026-02-09
Start date
2024-04-03
Completion date
2026-12-31
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Affective Disorder, Depression Disorders, Personality Disorders, Schizophrenia Disorders

Keywords

General Adult Psychiatry, mental health, physical health, inpatients, schizophrenia, NHS, Bipolar affective disorder, depression, psychosis, treatment resistance, personality disorder, cardiometabolic disease, cancer, respiratory disease

Brief summary

This observational study will characterise the general psychiatric and general medical phenotypes of 100 adults, sequentially admitted to NHS General Adult Psychiatry (GAP) "mental health" inpatient wards, providing the first detailed information on morbidity in this patient population.

Detailed description

It is often supposed that most patients who attend secondary care General Adult Psychiatry (GAP) services would be excluded from clinical trials because they have too many co-morbidities, they are 'treatment resistant' (have a condition that does not improve despite trying two or more standard treatments), and their conditions are too severe. Hence, it would be helpful to properly measure these variables in GAP patients using questionnaires and a review of the case notes to see how many GAP patients would indeed be excluded from clinical trials. It is anticipated that this will show that the participants in clinical trials are very different from 'real life' GAP patients, and that could explain why some promising results from clinical trials do not translate into useful new treatments. Also, this data could act as a benchmark or baseline against which to measure the efficacy of novel treatments and interventions. PRIMARY OBJECTIVE Using the most commonly employed diagnostic tools, severity rating scales, and a systematic review of the case notes, the typical characteristics of GAP patients will be described. SECONDARY OBJECTIVES The above data will be used to compared 'typical/real life' patients with the participants in impactful clinical trials. This is a cross sectional quantitative study. Participants will spend about an hour attending to the questionnaires and talking to their clinician. STUDY SETTING The study will take place in St John's Hospital, Livingston, West Lothian, on the acute psychiatric ward, and the outpatient department. STUDY POPULATION 100 patients who attend the West Lothian NHS GAP service will be consecutively recruited. These participants will be between 18 and 65 years old and suffering from mental disorders that their GP could not treat. IDENTIFYING PARTICIPANTS The usual clinical team will ask eligible patients if they would like to participate. CONSENTING PARTICIPANTS Consent will be thoroughly informed by an information leaflet and subsequent discussion with the involved clinician. Participants will take the information leaflet away with them and express their consent, or not, in their own time by using the contact details on the information leaflet, or when they next see their clinician. WITHDRAWAL OF STUDY PARTICIPANTS Participants will have the option of withdrawal from all aspects of the trial, but the data collected up to that point could be used. To safeguard rights, the minimum personally identifiable information possible will be collected. There are no stopping rules. Participants could withdraw at any time.

Interventions

OTHERQuestionnaires, rating scales, & review of notes

Observational - questionnaires, rating scales, \& review of notes

Sponsors

University of Edinburgh
Lead SponsorOTHER
University of Dundee
CollaboratorOTHER
NHS Lothian
CollaboratorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Inclusion: \- Adults aged between 18 and 65 years admitted to GAP wards during recruitment period Exclusion: \- Admissions to non-GAP wards (e.g., forensic psychiatry, young people's units, perinatal, old age psychiatry, or general medical wards)

Design outcomes

Primary

MeasureTime frameDescription
Rates of comorbid physical illnessesAt enrolmentAs per medical note review and physical examination - BMI
Psychiatric diagnosisAt enrolmentICD-11 codes
Severity of psychosisAt enrolmentBrief Psychiatric Rating Scale (BPRS) score; 18 to 126, higher scores indicate more severe symptoms
Depression of severityAt enrolmentInventory of Depressive Symptomatology Self Report (IDS-SR); 0 to 84, higher scores indicate more severe symptoms
Severity of maniaAt enrolmentYoung Mania Rating Scale score; 0 to 60, higher scores indicate more severe symptoms
Severity of anxietyAt enrolmentGeneral Anxiety Scale (GAD-7) score; 0 to 21, higher scores indicate more severe symptoms
Substance useAt enrolmentTobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool score; tobacco 0 to 3, alcohol 0 to 4, others 0 to 21, higher scores indicate more risky use
Mental Health Act statusAt enrolmentMHA detention status; informal or detained
Treatment resistance indicatorsAt enrolmentClozapine for psychosis, and ECT treatment and Massachusetts General Hospital Staging (MGH-S) score for depression. MGH-S uses the number of failed trials with the intensity/optimization of each trial to produce a score where \>3.5 defines treatment resistant depression
Rates of abnormal findings on physical examinationAt enrolmentWhen psychiatric patients are admitted to hospital, they are examined by a resident doctor, including inspection, auscultation, and palpation. Rates of abnormal findings on cardiovascular , respiratory, abdominal, and neurological examination will be noted..
Abnormal laboratory valuesAt enrolmentWhen psychiatric patients are admitted to hospital, screening blood tests, including full blood count, urea and electrolytes (kidney), liver function tests, random glucose, cholesterol, triglycerides, and thyroid function tests.
Rates of comorbid physical illnessAt enrolmentAs per medical note review and physical examination - blood pressure mmHg

Countries

United Kingdom

Contacts

CONTACTDavid Hayward
david.hayward@nhslothian.scot.nhs.uk01506 523000
STUDY_DIRECTORDouglas Steele

University of Dundee

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026